Compare CWST & MMSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CWST | MMSI |
|---|---|---|
| Founded | 1975 | 1987 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Environmental Services | Medical/Dental Instruments |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.8B | 4.8B |
| IPO Year | 1997 | 1990 |
| Metric | CWST | MMSI |
|---|---|---|
| Price | $94.53 | $84.16 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 8 | 8 |
| Target Price | ★ $119.50 | $105.38 |
| AVG Volume (30 Days) | 542.6K | ★ 625.1K |
| Earning Date | 10-30-2025 | 10-30-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 102.54 | N/A |
| EPS | 0.24 | ★ 1.95 |
| Revenue | ★ $1,795,272,000.00 | $1,477,128,000.00 |
| Revenue This Year | $20.34 | $13.53 |
| Revenue Next Year | $7.68 | $6.30 |
| P/E Ratio | $396.29 | ★ $43.13 |
| Revenue Growth | ★ 20.54 | 11.41 |
| 52 Week Low | $82.22 | $78.12 |
| 52 Week High | $121.24 | $111.45 |
| Indicator | CWST | MMSI |
|---|---|---|
| Relative Strength Index (RSI) | 58.51 | 44.22 |
| Support Level | $94.75 | $83.84 |
| Resistance Level | $97.21 | $88.71 |
| Average True Range (ATR) | 2.34 | 2.37 |
| MACD | 0.31 | -0.38 |
| Stochastic Oscillator | 69.40 | 46.97 |
Casella Waste Systems Inc is a solid waste removal company, providing resource management services to residential, commercial, municipal, and industrial customers. The company's reportable segments on Geographical basis include Eastern, Western and Mid-Atlantic regions through the Resource solution segment. It generates maximum revenue from the Western region segment. The company's services include Recycling, Collection, Organics, Energy, Landfills, Special Waste as well as Professional Services.
Merit Medical Systems Inc is a medical equipment company that develops and manufactures products for interventional cardiology, radiology, and endoscopy procedures. The firm reports two segments which are Cardiovascular and Endoscopy. The majority of the revenue is earned from the Cardiovascular segment which consists of cardiology and radiology medical device products that assist in diagnosing and treating coronary artery disease, peripheral vascular disease, and other non-vascular diseases and includes embolotherapeutic, cardiac rhythm management, electrophysiology, critical care, and interventional oncology and spine devices.